Today: 21 May 2026
Rigetti (RGTI) stock ends 2025 lower as year-end selling hits quantum names — what to watch next

Rigetti (RGTI) stock ends 2025 lower as year-end selling hits quantum names — what to watch next

NEW YORK, December 31, 2025, 20:16 ET — Market closed

  • Rigetti Computing shares closed down 1.2% at $22.15 and last traded higher in late trading.
  • Quantum-computing peers also slipped as Wall Street ended 2025 lower in holiday-thin volume.
  • U.S. markets are closed Thursday for New Year’s Day; traders are watching early-January data and the next earnings window.

Rigetti Computing shares closed down 1.2% on Wednesday at $22.15, ending the final session of 2025 lower as investors trimmed exposure to quantum-computing plays in thin year-end trade.

The move mattered more for what it signaled than the size of the drop: holiday-shortened weeks can exaggerate risk-off flows, and speculative technology names often feel it first when liquidity dries up.

With U.S. markets closed on Thursday for New Year’s Day, positioning for the first full session of 2026 will be in focus as investors gauge whether demand returns when normal volumes resume.

Rigetti traded between $21.93 and $22.67 on Wednesday, with about 23.0 million shares changing hands. The stock last traded up about 0.5% in late trading at $22.26.

Other U.S.-listed quantum names also eased. IonQ fell about 1.0% to $44.87, D-Wave Quantum slipped 0.4% to $26.15 and Quantum Computing Inc dropped 1.4% to $10.26, according to market data.

“It’s perfectly fine in any bull market to have moments of cost,” said Giuseppe Sette, co-founder and president of Reflexivity, pointing to profit-taking opportunities when liquidity is low. Reuters

On Wall Street, the S&P 500 fell 0.74% and the Nasdaq Composite dropped 0.76% on Wednesday, Reuters reported, with trading volumes thin into year-end. The S&P 500 finished 2025 up 16.39%, while the Nasdaq rose 20.36%.

Rigetti, based in Berkeley, California, operates quantum computers over the cloud through its Rigetti Quantum Cloud Services platform and sells quantum processing units, or QPUs, alongside development contracts and related services, Reuters data showed.

The company markets “Quantum Computing as a Service,” meaning customers can access its machines via public or private cloud setups rather than owning the hardware. Its QPUs use superconducting qubits, the basic units of quantum computation, and the company designs and manufactures its chips in-house, Reuters said. Reuters

A key investor question heading into 2026 is pace: how quickly experimental projects in quantum move into repeatable, revenue-generating workloads, and how much capital is needed along the way. Rigetti posted 2024 revenue of $10.79 million and a net loss of $200.99 million, according to LSEG data cited by Reuters.

Before the next session, U.S. equity markets will be shut Thursday for New Year’s Day. Traders return Friday, Jan. 2, with early reads on growth and inflation back in play.

Macro data could set the tone quickly. The ISM manufacturing PMI report is due on Jan. 2, and S&P Global is scheduled to publish its final U.S. manufacturing PMI data for December on the same day.

The calendar thickens in the following week with the U.S. jobs report on Jan. 9 and December CPI on Jan. 13, ahead of the Federal Reserve’s Jan. 27–28 policy meeting. For Rigetti, traders will also watch whether the stock holds above Wednesday’s $21.93 low and can retake the $22.67 intraday high, with Wall Street tracking its next earnings window, expected in early March.

Stock Market Today

  • CyberTech Systems Earnings Raise Cash Flow Concerns Amid Market Stability
    May 20, 2026, 8:56 PM EDT. CyberTech Systems and Software Limited (NSE:CYBERTECH) posted earnings that met market expectations but revealed an accrual ratio of 0.53, indicating weaker free cash flow relative to profit. This financial metric, which measures non-cash earnings, signals potential challenges for upcoming profits as free cash flow of ₹76 million lagged behind reported profit of ₹304.3 million for the year ending March 2026. Despite a 28% annual growth in earnings per share (EPS) over three years, the decline in cash conversion may raise investor caution. The company's accrual ratio improved last year, suggesting the current shortfall could be temporary, but shareholders are advised to monitor cash flow trends closely against profitability for a clearer outlook.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
AI stocks today: Nvidia, AMD tick higher as year-end trade turns cautious
Previous Story

AI stocks today: Nvidia, AMD tick higher as year-end trade turns cautious

Outlook Therapeutics stock drops after FDA issues another Lytenava CRL for wet AMD
Next Story

Outlook Therapeutics stock drops after FDA issues another Lytenava CRL for wet AMD

Go toTop